國立高雄大學圖資館 |

Language: English

Back

Handbook of biologics for rheumatological disorders

Record Type:	Electronic resources : Monograph/item
Title/Author:	Handbook of biologics for rheumatological disordersedited by Neeraj Jain, Lalit Duggal.
other author:	Jain, Neeraj.
Published:	Singapore :Springer Singapore :2022.
Description:	x, 288 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	RheumatismChemotherapy.
Online resource:	https://doi.org/10.1007/978-981-16-7200-2
ISBN:	9789811672002$q(electronic bk.)

Handbook of biologics for rheumatological disorders
Handbook of biologics for rheumatological disorders[electronic resource] /edited by Neeraj Jain, Lalit Duggal. - Singapore :Springer Singapore :2022. - x, 288 p. :ill., digital ;24 cm.

History of Biologics -- Biologics in Rheumatoid Arthritis -- Biologics in Spondylarthritis -- Biologics in Psoriatic Arthritis -- Biologics in Gout -- Biologics in Lupus -- Biologics in Sjogren's Syndrome -- Biologics in Systemic Sclerosis -- Biologics in Inflammatory Myopathies -- Biologics in ANCA Associated Vasculitis -- Biologics inBehcet's Syndrome -- Biologicsin Takayasu's Arteritis -- Biologics in Interstitial lung disease in Rheumatological conditions -- Biologics in Osteoporosis -- Biologics in Osteoarthritis -- Biologics in JIA -- Biologics in Paediatric CTD -- JAK inhibitors in Rheumatology -- Biologics in Rheumatic disease with Infections -- Biologics in Rheumatological conditions with Malignancy -- Biologics in Uveitis -- Biologics in Sarcoidosis -- Biologics in IgG4-RD -- Biosimilar in Rheumatology -- Off label use of Biologics in Rheumatological disorders -- Biologics & Ethical issues in Rheumatology -- Patient consent for use of biologics.

Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens. This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field. This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest.

ISBN: 9789811672002$q(electronic bk.)

Standard No.: 10.1007/978-981-16-7200-2doiSubjects--Topical Terms:

925385
Rheumatism
--Chemotherapy.

LC Class. No.: RC927 / .H36 2022

Dewey Class. No.: 616.723061

Handbook of biologics for rheumatological disorders
LDR:03531nmm a2200325 a 4500 001 623258
003 DE-He213
005 20220306165951.0
006 m d
007 cr nn 008maaau
008 221209s2022 si s 0 eng d
020 $a 9789811672002$q(electronic bk.)
020 $a 9789811671999$q(paper)
024 7 $a 10.1007/978-981-16-7200-2 $2 doi
035 $a 978-981-16-7200-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC927 $b .H36 2022
072 7 $a MJ $2 bicssc
072 7 $a MED083000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616.723061 $2 23
090 $a RC927 $b .H236 2022
245 0 0 $a Handbook of biologics for rheumatological disorders $h [electronic resource] / $c edited by Neeraj Jain, Lalit Duggal.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2022.
300 $a x, 288 p. : $b ill., digital ; $c 24 cm.
505 0 $a History of Biologics -- Biologics in Rheumatoid Arthritis -- Biologics in Spondylarthritis -- Biologics in Psoriatic Arthritis -- Biologics in Gout -- Biologics in Lupus -- Biologics in Sjogren's Syndrome -- Biologics in Systemic Sclerosis -- Biologics in Inflammatory Myopathies -- Biologics in ANCA Associated Vasculitis -- Biologics inBehcet's Syndrome -- Biologicsin Takayasu's Arteritis -- Biologics in Interstitial lung disease in Rheumatological conditions -- Biologics in Osteoporosis -- Biologics in Osteoarthritis -- Biologics in JIA -- Biologics in Paediatric CTD -- JAK inhibitors in Rheumatology -- Biologics in Rheumatic disease with Infections -- Biologics in Rheumatological conditions with Malignancy -- Biologics in Uveitis -- Biologics in Sarcoidosis -- Biologics in IgG4-RD -- Biosimilar in Rheumatology -- Off label use of Biologics in Rheumatological disorders -- Biologics & Ethical issues in Rheumatology -- Patient consent for use of biologics.
520 $a Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens. This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field. This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest.
650 0 $a Rheumatism $x Chemotherapy. $3 925385
650 0 $a Biologicals. $3 667671
650 1 4 $a Internal Medicine. $3 273839
700 1 $a Jain, Neeraj. $3 925383
700 1 $a Duggal, Lalit. $3 925384
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-7200-2
950 $a Medicine (SpringerNature-11650)